Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Onabotulinum Toxin A to Improve Direct Brow Lift Outcomes

NCT04383912 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04383912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Onabotulinum Toxin A to Improve Direct Brow Lift Outcomes
Lead sponsor
Nova Scotia Health Authority
Phase
Not applicable
Overall status
Unknown status
Start date
November 18, 2020
Completion date
July 31, 2024
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

direct brow lift, scarring